Advertisement
Screener

Ernexa Therapeutics Inc. (ERNA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Ernexa Therapeutics Inc. Cash Flow Breakdown

Cash flow breakdown shows where Ernexa Therapeutics Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $7.02M went out.
  • Fiscal year ended 2025-12-31: from investing, $37.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $7.21M came in.
  • Fiscal year ended 2025-12-31: change in cash, $155.00K came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$7.02M-$37.00K$4.93M$2.28M*$155.00K
2024-12-31-$15.84M-$365.00K$1.14M$5.12M*-$9.94M
2023-12-31-$20.41M-$19.00K$0.00$0.00$16.56M*-$3.87M
2022-12-31-$20.98M-$47.00K-$5.00K$19.71M-$1.44M
2021-12-31-$23.49M-$22.74M$0.00$0.00$61.59M*$15.36M
2020-12-31-$8.10M-$39.00K-$2.75M$3.13M-$46.00K$0.00$4.34M*-$2.63M
2019-12-31$2.74M-$1.06M-$1.00M-$37.00K$623.00K
2018-12-31$1.36M-$1.58M-$5.37M$4.00M$1.07M*-$592.00K
2017-12-31$549.00K-$1.45M-$3.04M$50.00K$1.77M-$2.37M
2016-12-31$23.00K-$840.00K-$1.83M$2.50M$2.69M$2.44M
2015-12-31-$4.18M-$1.62M-$4.62M$6.74M-$3.82M
2014-12-31-$6.38M-$1.90M-$2.32M$6.05M-$33.00K$6.37M$1.79M
2013-12-31$1.74M-$2.70M-$16.00K$0.00$3.77M*$2.79M
2012-12-31$2.16M-$2.78M$0.00$1.95M*$1.33M
2011-12-31$574.00K-$2.79M$36.00K-$2.52M
2010-12-31$2.83M-$2.20M$61.00K$264.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDividendsDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$4.15M*-$3.00K*
2026-03-31-$2.26M-$2.00K$10.48M-$921.00K*$7.29M
2025-12-31-$1.15M*-$15.00K*$0.00*
2025-09-30-$1.27M*$0.00*
2025-06-30-$2.53M*$4.93M*
2025-03-31-$2.06M$2.25M*$189.00K
2024-12-31-$3.54M*$0.00*$1.01M*
2024-09-30-$6.29M*-$19.00K*$3.89M*
2024-06-30-$2.26M*-$249.00K*
2024-03-31-$3.75M-$97.00K$1.39M*-$2.46M
2023-12-31-$4.66M*-$19.00K*$0.00*$0.00*$7.70M*
2023-09-30-$5.83M*$0.00*$0.00*$0.00*$8.54M*
2023-06-30-$3.87M*$0.00*$0.00*
2023-03-31-$6.05M$0.00$0.00-$6.05M
2022-12-31-$5.43M*$129.00K*$0.00*$7.71M*
2022-09-30-$6.12M*-$43.00K*$0.00*$0.00*
2022-06-30-$3.99M*-$87.00K*$0.00*
2022-03-31-$5.43M-$46.00K$11.99M$6.51M
2021-12-31-$6.83M*-$147.00K*$0.00*$0.00*
2021-09-30-$6.42M*-$22.86M*$0.00*$0.00*$3.50M*
2021-06-30-$6.80M*-$1.00K*$0.00*$48.56M*
2021-03-31-$3.43M$267.00K$0.00$9.94M*$6.78M
2020-12-31-$1.64M*-$12.82K*-$725.00K*$500.00K*-$10.00K*$0.00*
2020-09-30-$2.41M*$0.00*-$900.00K*$1.00M*-$9.00K*$0.00*$60.00K*
2020-06-30-$2.18M*-$21.72K*-$375.00K*-$7.00K*$0.00*$4.24M*
2020-03-31-$1.87M-$4.46K-$750.00K-$20.00K$1.17M-$988.00K
2019-12-31$983.00K*-$101.00K*-$250.00K*-$8.00K*
2019-09-30$422.00K*-$246.00K*$0.00*-$333.00K*-$16.00K*
2019-06-30$559.00K*-$322.00K*-$167.00K*-$8.00K*
2019-03-31$780.00K-$396.00K-$250.00K-$5.00K$130.00K
2018-12-31$837.00K*-$598.00K*-$354.00K*$0.00*$0.00*
2018-09-30$289.00K*-$277.00K*$0.00*-$4.66M*-$6.00K*$3.92M*-$728.00K*
2018-06-30$359.00K*-$332.00K*-$182.00K*$1.33M*$1.17M*
2018-03-31-$120.00K-$372.00K-$182.00K-$718.00K
2017-12-31-$507.00K*-$334.00K*-$181.00K*$0.00*-$1.08M*
2017-09-30-$1.75M*-$417.00K*-$206.00K*$0.00*-$2.41M*
2017-06-30$3.27M*-$452.00K*-$2.29M*$219.00K*$700.00K*
2017-03-31-$466.00K-$249.00K-$359.00K$1.55M$420.00K
2016-12-31$51.00K*-$156.00K*-$261.00K*$388.00K*$2.67M*$2.69M*
2016-09-30-$41.00K*-$218.00K*-$257.00K*$0.00*-$543.00K*
2016-06-30$517.00K*-$190.00K*-$276.00K*$0.00*$22.00K*
2016-03-31-$504.00K-$276.00K-$1.03M$2.11M$273.00K
2015-12-31-$1.96M*-$331.00K*-$222.00K*$1.10M*-$1.43M*
2015-09-30-$1.09M*-$477.00K*-$129.00K*$1.06M*$0.00*$0.00*-$646.00K*
2015-06-30-$2.13M*-$378.00K*-$3.57M*$4.50M*$0.00*-$1.67M*
2015-03-31$995.00K-$437.00K-$699.00K$74.00K$0.00$0.00-$74.00K
2014-12-31-$2.95M*-$525.00K*-$872.00K*$1.73M*$0.00*$0.00*-$2.62M*
2014-09-30-$1.45M*-$596.00K*-$553.00K*$1.30M*-$6.00K*$0.00*-$1.29M*
2014-06-30-$1.54M*-$260.00K*-$12.00K*$17.00K$8.16M*$6.37M*
2014-03-31-$453.00K-$520.00K-$15.00K$6.00K-$663.00K
2013-12-31$769.00K*-$1.05M*-$6.00K*$0.00*$3.61M*$3.32M*
2013-09-30$723.00K*-$664.00K*-$3.00K*$0.00*$175.00K*
2013-06-30$180.00K*-$595.00K*$0.00*-$325.00K*
2013-03-31$166.00K-$484.00K$0.00-$379.00K
2012-12-31$1.16M*-$750.00K*$331.00K*
2012-09-30$397.00K*-$490.00K*-$179.00K*
2012-06-30$342.00K*-$825.00K*-$569.00K*
2012-03-31$255.00K-$712.00K$2.21M*$1.75M
2011-12-31-$127.00K*-$862.00K*$0.00*-$1.11M*
2011-09-30-$118.00K*-$498.00K*$2.00K*-$590.00K*
2011-06-30-$85.00K*-$748.00K*$0.00*-$944.00K*
2011-03-31$904.00K-$682.00K$34.00K$126.00K
2010-12-31$628.00K*-$469.00K*$36.00K*
2010-09-30$1.33M*-$644.00K*$584.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pulmatrix, Inc. (PULM)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
SYNLOGIC, INC. (SYBX)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B